IL148942A0 - C-peptide for the improved production of insulin and insulin analogues - Google Patents

C-peptide for the improved production of insulin and insulin analogues

Info

Publication number
IL148942A0
IL148942A0 IL14894200A IL14894200A IL148942A0 IL 148942 A0 IL148942 A0 IL 148942A0 IL 14894200 A IL14894200 A IL 14894200A IL 14894200 A IL14894200 A IL 14894200A IL 148942 A0 IL148942 A0 IL 148942A0
Authority
IL
Israel
Prior art keywords
insulin
chain
amino acid
human insulin
peptide
Prior art date
Application number
IL14894200A
Other languages
English (en)
Original Assignee
Aventis Pharma Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Gmbh filed Critical Aventis Pharma Gmbh
Publication of IL148942A0 publication Critical patent/IL148942A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/62—Insulins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
IL14894200A 1999-10-02 2000-09-15 C-peptide for the improved production of insulin and insulin analogues IL148942A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19947456A DE19947456A1 (de) 1999-10-02 1999-10-02 C-Peptid zur verbesserten Herstellung von Insulin und Insulinanaloga
PCT/EP2000/009017 WO2001025278A1 (fr) 1999-10-02 2000-09-15 Peptide c servant a ameliorer la production d'insuline et d'analogues de cette derniere

Publications (1)

Publication Number Publication Date
IL148942A0 true IL148942A0 (en) 2002-09-12

Family

ID=7924253

Family Applications (2)

Application Number Title Priority Date Filing Date
IL14894200A IL148942A0 (en) 1999-10-02 2000-09-15 C-peptide for the improved production of insulin and insulin analogues
IL148942A IL148942A (en) 1999-10-02 2002-03-31 Pre-insulin with C-peptide modified for improved insulin production and insulin analogues

Family Applications After (1)

Application Number Title Priority Date Filing Date
IL148942A IL148942A (en) 1999-10-02 2002-03-31 Pre-insulin with C-peptide modified for improved insulin production and insulin analogues

Country Status (25)

Country Link
US (1) US6534288B1 (fr)
EP (1) EP1222207B1 (fr)
JP (1) JP4681784B2 (fr)
KR (1) KR100823463B1 (fr)
CN (1) CN1193042C (fr)
AT (1) ATE380196T1 (fr)
AU (1) AU778369B2 (fr)
BR (2) BRPI0014464B8 (fr)
CA (1) CA2385857C (fr)
CY (1) CY1107860T1 (fr)
DE (2) DE19947456A1 (fr)
DK (1) DK1222207T3 (fr)
ES (1) ES2295054T3 (fr)
HK (1) HK1049016B (fr)
HU (1) HU228313B1 (fr)
IL (2) IL148942A0 (fr)
MX (1) MXPA02003103A (fr)
NO (1) NO329975B1 (fr)
NZ (1) NZ518066A (fr)
PL (1) PL203195B1 (fr)
PT (1) PT1222207E (fr)
SI (1) SI1222207T1 (fr)
TW (1) TWI265168B (fr)
WO (1) WO2001025278A1 (fr)
ZA (1) ZA200202520B (fr)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7176278B2 (en) 2001-08-30 2007-02-13 Biorexis Technology, Inc. Modified transferrin fusion proteins
US20050250676A1 (en) * 2001-11-19 2005-11-10 Aventis Pharma Deutschland Gmbh Method of activating insulin receptor substrate-2 to stimulate insulin production
US20040038864A1 (en) * 2002-06-27 2004-02-26 Per Balschmidt Use of dimethyl sulfone as isotonicity agent
DE10235168A1 (de) * 2002-08-01 2004-02-12 Aventis Pharma Deutschland Gmbh Verfahren zur Reinigung von Preproinsulin
EP1692168B1 (fr) * 2003-12-03 2011-07-20 Novo Nordisk A/S Insuline monocatenaire
CN1663960B (zh) * 2004-03-01 2012-07-04 重庆富进生物医药有限公司 高效表达重组人胰岛素原及其类似物的新型c肽
WO2007121318A2 (fr) * 2006-04-12 2007-10-25 Emisphere Technologies, Inc. Préparations destinées à l'administration d'insuline
CA2711752A1 (fr) 2008-01-09 2009-07-16 Sanofi-Aventis Deutschland Gmbh Nouveaux derives d'insuline a profil temporel/d'action extremement retarde
DE102008003568A1 (de) 2008-01-09 2009-07-16 Sanofi-Aventis Deutschland Gmbh Neue Insulinderivate mit extrem verzögertem Zeit-/ Wirkungsprofil
DE102008025007A1 (de) 2008-05-24 2009-11-26 Sanofi-Aventis Deutschland Gmbh Neue Insulinderivate mit extrem verzögertem Zeit-/ Wirkungsprofil
DE102008003566A1 (de) 2008-01-09 2009-07-16 Sanofi-Aventis Deutschland Gmbh Neue Insulinderivate mit extrem verzögertem Zeit-/ Wirkungsprofil
DE102008025008A1 (de) 2008-05-24 2009-11-26 Sanofi-Aventis Deutschland Gmbh Neue Insulinderivate mit extrem verzögertem Zeit-/ Wirkungsprofil
PL2229407T3 (pl) * 2008-01-09 2017-06-30 Sanofi-Aventis Deutschland Gmbh Nowe pochodne insuliny o ekstremalnie spowolnionym profilu czasu działania
PT3228320T (pt) 2008-10-17 2020-03-26 Sanofi Aventis Deutschland Combinação de uma insulina e de um agonista do glp-1
JP5973918B2 (ja) 2009-11-13 2016-08-23 サノフィ−アベンティス・ドイチュラント・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツング Ｇｌｐ−１アゴニスト及びメチオニンを含む薬学的組成物
TR201809460T4 (tr) 2009-11-13 2018-07-23 Sanofi Aventis Deutschland Bir GLP- 1-agonisti, bir insülin ve metiyonin içeren farmasötik bileşim.
JP6199186B2 (ja) 2010-08-30 2017-09-20 サノフィ−アベンティス・ドイチュラント・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツング ２型糖尿病の治療用の医薬の製造のためのａｖｅ００１０の使用
US9821032B2 (en) 2011-05-13 2017-11-21 Sanofi-Aventis Deutschland Gmbh Pharmaceutical combination for improving glycemic control as add-on therapy to basal insulin
AR087693A1 (es) 2011-08-29 2014-04-09 Sanofi Aventis Deutschland Combinacion farmaceutica para uso en el control glucemico en pacientes con diabetes de tipo 2
TWI559929B (en) 2011-09-01 2016-12-01 Sanofi Aventis Deutschland Pharmaceutical composition for use in the treatment of a neurodegenerative disease
TWI780236B (zh) 2013-02-04 2022-10-11 法商賽諾菲公司 胰島素類似物及/或胰島素衍生物之穩定化醫藥調配物
MX2016008979A (es) 2014-01-09 2016-10-04 Sanofi Sa Formulaciones farmaceuticas estabilizadas de analogos de insulina y/o derivados de insulina.
BR112016015851A2 (pt) 2014-01-09 2017-08-08 Sanofi Sa Formulações farmacêuticas estabilizadas de insulina aspart
CN105899191B (zh) 2014-01-09 2020-06-16 赛诺菲 胰岛素类似物和/或胰岛素衍生物的稳定化不含甘油的药物制剂
CA2970200A1 (fr) 2014-12-12 2016-06-16 Sanofi-Aventis Deutschland Gmbh Formulation contenant un rapport fixe d'insuline glargine/lixisenatide
TWI748945B (zh) 2015-03-13 2021-12-11 德商賽諾菲阿凡提斯德意志有限公司 第２型糖尿病病患治療
TW201705975A (zh) 2015-03-18 2017-02-16 賽諾菲阿凡提斯德意志有限公司 第２型糖尿病病患之治療

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PH16156A (en) * 1980-03-27 1983-07-18 Lilly Co Eli Process for producing an insulin precursor
US4430266A (en) * 1980-11-28 1984-02-07 Eli Lilly And Company Process for producing an insulin precursor
HRP940432B1 (en) * 1994-08-05 2003-10-31 Pliva Pharm & Chem Works Dna sequences encoding biosynthetic insulin precursors and process for preparation of insulin
PT821006E (pt) * 1996-07-26 2004-09-30 Aventis Pharma Gmbh Derivados de insulina com ligacao a zinco aumentada
DE19726167B4 (de) * 1997-06-20 2008-01-24 Sanofi-Aventis Deutschland Gmbh Insulin, Verfahren zu seiner Herstellung und es enthaltende pharmazeutische Zubereitung

Also Published As

Publication number Publication date
DK1222207T3 (da) 2008-03-17
PL354078A1 (en) 2003-12-15
CY1107860T1 (el) 2013-06-19
JP4681784B2 (ja) 2011-05-11
EP1222207A1 (fr) 2002-07-17
HU228313B1 (en) 2013-03-28
TWI265168B (en) 2006-11-01
ATE380196T1 (de) 2007-12-15
EP1222207B1 (fr) 2007-12-05
HUP0202755A3 (en) 2005-01-28
DE19947456A1 (de) 2001-04-05
CA2385857C (fr) 2012-05-22
KR20020047209A (ko) 2002-06-21
BR0014464A (pt) 2002-06-11
HK1049016A1 (en) 2003-04-25
JP2003511018A (ja) 2003-03-25
CN1193042C (zh) 2005-03-16
ES2295054T3 (es) 2008-04-16
NO20021335L (no) 2002-06-03
PL203195B1 (pl) 2009-09-30
HUP0202755A2 (hu) 2002-12-28
MXPA02003103A (es) 2002-09-30
NZ518066A (en) 2004-05-28
IL148942A (en) 2010-02-17
WO2001025278A1 (fr) 2001-04-12
ZA200202520B (en) 2002-12-24
AU7287700A (en) 2001-05-10
NO329975B1 (no) 2011-01-31
PT1222207E (pt) 2008-02-11
US6534288B1 (en) 2003-03-18
KR100823463B1 (ko) 2008-04-21
CA2385857A1 (fr) 2001-04-12
AU778369B2 (en) 2004-12-02
HK1049016B (zh) 2005-10-14
SI1222207T1 (sl) 2008-04-30
BRPI0014464B8 (pt) 2021-05-25
CN1377370A (zh) 2002-10-30
DE50014830D1 (de) 2008-01-17
NO20021335D0 (no) 2002-03-18
BRPI0014464B1 (pt) 2018-03-13

Similar Documents

Publication Publication Date Title
HK1049016A1 (en) C-peptide for the improved production of insulin and insulin analogues.
DE69020794D1 (de) Enzymatische Entfernung einer aminoterminalen Proteinsequenz.
EP0262399A3 (en) Cyclic enol derivatives, production and use thereof
EA200000748A1 (ru) Способ введения мономерных аналогов инсулина
EP1411968A4 (fr) Glp-1, exendine-4, analogues peptidiques et utilisations associees
ATE443082T1 (de) Insulinvorstufen und verfahren zu deren herstellung
HK1056179A1 (en) Oxidation process for preparing the intermediate 6.alpha., 9.alpha.- difluoro-11.beta., 17.alpha.-dihydroxy-16.alpha.-methyl-androst-1,4-dien-3- one 17.beta.-carboxylic acid
DE60044728D1 (de) VERFAHREN ZUR HERSTELLUNG VON INSULINVORLäUFERN UND ANALOGEN VON INSULINVORLÄUFERN MIT VERBESSERTER FERMENTATIONSAUSBEUTE IN HEFE
MA27982A1 (fr) Preparation de peptides somatostatine
ITRM20000340A0 (it) Uso dell'acido pamoico o di un suo derivato, o di un suo analogo, perla preparazione di un medicamento per il trattamento di patologie cara
MXPA03011004A (es) Derivados de fenilalquiloxi-fenilo novedosos.
WO2001064715A3 (fr) Peptides memno et procede de preparation et d"utilisation associe
IL166261A0 (en) Monomeric insulin
EP0173527A3 (fr) Analogues de la somatostatine insuline-sélective
YU63402A (sh) Memno peptidi, postupak za njihovo pripremanje i njihova primena